
GITLAB INC-CL A
GTLBNASDAQ๐ #956 by market capEarnings Sep 8US Equity
$42.11โฒ $1.43 (+3.39%)
๐
Pre-market$41.64โผ 1.12%Regular close ยท extended-hours price shown1hโ
24hโฒ 3.4%
7dโฒ 16.5%
14dโฒ 23.7%
30dโฒ 25.8%
1yโฒ 7.3%
๐ฆMarket Cap
$7.11B
Small Cap
๐Revenue Growth (YoY)
+24.9%
Healthy
๐Gross Margin
86.8%
High
๐ตFCF Margin
26.2%
Strong
โ๏ธP/S Ratio
6.8x
Fair
Otter Score
53
Weak
๐
Analyst Ratings
Price
$42.11
Total
30
Raised
1
Lowered
5
Avg PT
$34.71
H / L
$60 / $26
| Institution | Action | Rating | Date |
|---|---|---|---|
UBS | Reiterated | Neutral | 2026-07-10 |
Truist Securities | Reiterated | Hold | 2026-07-09 |
Macquarie | Reiterated | Neutral | 2026-06-12 |
BTIG | Reiterated | Buy | 2026-06-11 |
TD Cowen | Reiterated | Hold | 2026-06-03 |
Morgan Stanley | Reiterated | Equal Weight | 2026-06-03 |
JP Morgan | Reiterated | Neutral | 2026-06-03 |
Cantor Fitzgerald | Reiterated | Neutral | 2026-06-03 |
Rosenblatt | Reiterated | Buy | 2026-06-03 |
DA Davidson | Reiterated | Neutral | 2026-06-03 |
Needham | Reiterated | Buy | 2026-06-03 |
Mizuho | Reiterated | Neutral | 2026-06-03 |
RBC Capital | Reiterated | Sector Perform | 2026-06-03 |
Guggenheim | Reiterated | Neutral | 2026-06-03 |
Raymond James | Downgraded | Outperform โ Market Perform | 2026-05-12 |
B of A Securities | Downgraded | Buy โ Neutral | 2026-04-22 |
William Blair | Downgraded | Outperform โ Underperform | 2026-03-23 |
Piper Sandler | Downgraded | Overweight โ Neutral | 2026-03-04 |
Barclays | Reiterated | Underweight | 2026-03-04 |
Canaccord Genuity | Reiterated | Buy | 2026-03-04 |
Wells Fargo | Reiterated | Equal Weight | 2026-03-04 |
Bernstein | Reiterated | Outperform | 2026-03-04 |
Keybanc | Downgraded | Overweight โ Sector Weight | 2025-12-16 |
Goldman Sachs | Reiterated | Neutral | 2025-12-03 |
Scotiabank | Reiterated | Sector Outperform | 2025-06-11 |
Baird | Reiterated | Outperform | 2025-03-03 |
Wolfe Research | Upgraded | Peer Perform โ Outperform | 2024-03-06 |
FBN Securities | Reiterated | Outperform | 2023-01-23 |
MoffettNathanson | Reiterated | Buy | 2022-09-22 |
Cowen & Co. | Reiterated | Outperform | 2021-12-07 |
One row per institution, most recent rating